208 related articles for article (PubMed ID: 7921968)
1. Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors.
Canals C; Marti JM; Martinez E; Sierra J; Punti C; Granena A; Domingo A; Cubells J; Brunet S; Badell I
J Hematother; 1993; 2(1):75-85. PubMed ID: 7921968
[TBL] [Abstract][Full Text] [Related]
2. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
[TBL] [Abstract][Full Text] [Related]
3. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia.
Mehta J; Powles R; Horton C; Treleaven J; Singhal S
Bone Marrow Transplant; 1996 Aug; 18(2):319-24. PubMed ID: 8864441
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
6. Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S
Leuk Res; 1993 Jan; 17(1):61-7. PubMed ID: 8429681
[TBL] [Abstract][Full Text] [Related]
7. [Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity].
Schrøder H; Clausen N; Thorling K; Hokland P
Ugeskr Laeger; 1993 May; 155(20):1536-9. PubMed ID: 8316985
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
9. Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.
Hill RS; Mazza P; Amos D; Buckner CD; Appelbaum FR; Martin P; Still BJ; Sica S; Berenson R; Bensinger W
Bone Marrow Transplant; 1989 Jan; 4(1):69-74. PubMed ID: 2647189
[TBL] [Abstract][Full Text] [Related]
10. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay.
al-Fiar F; Prince HM; Imrie K; Stewart AK; Crump M; Keating A
Cell Transplant; 1997; 6(5):491-5. PubMed ID: 9331500
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of curative effect of autologous peripheral blood stem cell transplantation versus bone marrow transplantation for acute leukemia].
Zhang YZ; Zhang BL; Yao SQ; Liu HC; Lou FD; Gao CJ; Han XP; Wu XX; Zhao Y; Wang QS; Jing Y; Zhang M; Jin HJ; Shi ZJ; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):81-5. PubMed ID: 12667296
[TBL] [Abstract][Full Text] [Related]
13. Myeloid progenitors in remission bone marrow in patients with malignant blood diseases: clues for slow hematopoietic regeneration after ABMT?
Hokland P; Nielsen B; Ellegaard J; Palshof T; Hokland M
J Hematother; 1996 Jun; 5(3):279-88. PubMed ID: 8817395
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of combination drug purging for autologous bone marrow transplantation.
Rowley SD; Miller CB; Piantadosi S; Davis JM; Santos GW; Jones RJ
J Clin Oncol; 1991 Dec; 9(12):2210-8. PubMed ID: 1960561
[TBL] [Abstract][Full Text] [Related]
15. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
[TBL] [Abstract][Full Text] [Related]
16. Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia.
Herrmann RP; O'Reilly J; Meyer BF; Lazzaro G
Bone Marrow Transplant; 1992 Sep; 10(3):293-5. PubMed ID: 1358379
[TBL] [Abstract][Full Text] [Related]
17. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
[TBL] [Abstract][Full Text] [Related]
18. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
Damon LE; Rugo HS; Ries CA; Linker CA
Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
[TBL] [Abstract][Full Text] [Related]
19. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
20. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]